Valuation: Novonesis A/S

Market Cap 205B 30.1B 27.43B 25.39B 22.96B 43.08B 2,811B 45.09B 307B 122B 1,519B 113B 111B 4,812B P/E 2026 *
36.8x
P/E 2027 * 32x
Enterprise Value 225B 33.05B 30.11B 27.87B 25.21B 47.3B 3,086B 49.5B 337B 134B 1,668B 124B 121B 5,283B EV / Sales 2026 *
6.73x
EV / Sales 2027 * 6.22x
Free-Float
74.08%
Yield 2026 *
1.65%
Yield 2027 * 1.84%
1 day-2.44%
1 week-2.76%
Current month-4.76%
1 month-3.25%
3 months+5.95%
6 months+18.92%
Current year+7.90%
1 week 440
Extreme 440
461.6
1 month 439.8
Extreme 439.8
484.7
Current year 336.8
Extreme 336.8
484.7
1 year 336.8
Extreme 336.8
484.7
3 years 336.8
Extreme 336.8
489.4
5 years 274.6
Extreme 274.6
545.8
10 years 220.7
Extreme 220.7
545.8
Date Insider Type Main position Quantity % Market Cap. Importance
21/11/25 Buy

Director

2,500 0.0006%
21/11/25 Buy

Director

2,500 0.0006%
07/11/25 Buy

Head of Human Resources

380 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-2.44%-2.76%+9.92%+22.22% 30.82B
-1.12%-3.42%+16.29%+61.28% 84.33B
-0.69%-0.73%+22.85%+25.55% 44.69B
-2.21%-1.92%+23.63%+20.54% 36.69B
-1.82%-4.25%+25.51%-20.99% 36.05B
+0.81%+4.48%+17.01%+29.55% 27.21B
-0.12%-1.83%+56.26%+33.95% 23.06B
-0.36%-3.80%+28.93%-29.94% 19.91B
-1.83%-12.59%-19.44%-5.55% 13.92B
-1.89%-0.23%-4.47%+64.01% 14.12B
Average -1.11%-1.75%+17.65%+20.06% 33B
Weighted average by Cap. -1.13%-1.39%+19.62%+26.63%

Financials

2026 *2027 *
Net sales 33.44B 4.91B 4.47B 4.14B 3.75B 7.03B 459B 7.35B 50.06B 19.86B 248B 18.42B 18.04B 785B 36.01B 5.29B 4.82B 4.46B 4.03B 7.57B 494B 7.92B 53.9B 21.38B 267B 19.83B 19.42B 845B
Net income 5.48B 805M 733M 679M 614M 1.15B 75.18B 1.21B 8.21B 3.26B 40.62B 3.02B 2.96B 129B 6.39B 938M 855M 791M 716M 1.34B 87.62B 1.41B 9.56B 3.79B 47.35B 3.52B 3.45B 150B
Net Debt 20.06B 2.95B 2.68B 2.48B 2.25B 4.22B 275B 4.41B 30.03B 11.91B 149B 11.05B 10.82B 471B 19.02B 2.79B 2.54B 2.36B 2.13B 4B 261B 4.18B 28.47B 11.29B 141B 10.48B 10.26B 446B
Projected Income Statement - Annual - Novonesis A/S
Logo Novonesis A/S
Novonesis A/S is the world's leading producer of enzymes and microorganisms for industrial companies. Net sales break down by market as follows: - agriculture, bioenergy and animal feed industries (35.8%); - food industries (33%); - cleaning and household care products industries (19.3%); - human nutritional health industries (11.9%). Net sales are geographically distributed as follows: Denmark (1.1%), Europe/Middle East/Africa (34.6%), North America (32%), Asia/Pacific (18.7%), and Latin America (13.6%).
Employees
11,098
Date Price Change Volume
19/11/26 DKK 440.00 -2.44% 507,842
18/11/26 DKK 451.00 -0.09% 498,218
17/11/26 DKK 451.40 +0.18% 709,435
16/11/26 DKK 450.60 -1.81% 589,407
13/11/26 DKK 458.90 +1.59% 563,607
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Novonesis A/S
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
440.00DKK
Average target price
513.67DKK
Spread / Average Target
+16.74%
  1. Stock Market
  2. Stocks
  3. NSIS B Stock